The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases

Annals of the Rheumatic Diseases

Volumn 67, Issue 9, 2008, Pages 1287-1291

  Eike, M C ^a,b   Nordang, G B N ^a,b   Karlsen, T H ^a,b   Boberg, K M ^a   Vatn, M H ^a,c   Dahl Jorgensen K ^d   Ronningen K S ^e   Joner, G ^d   Flato B ^a   Bergquist, A ^f   Thorsby, E ^a,b   Forre O ^a   Kvien, T K ^g   Undlien, D E ^b,d   Lie, B A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR LIKE 3; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCANDINAVIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

EID: 50249119147     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077826     Document Type: Article

References (44)

1. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature 2005;435:584-9.
2. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979-84.
3. Lie BA, Thorsby E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol 2005;17:526-31.
4. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006;12:90-8.
5. Chistiakov DA, Chistiakov AP. Is FCRL3 a new general autoimmunity gene? Hum Immunol 2007;68:375-83.
6. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-85.
7. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005;65:671-3.
8. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restticted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006;54:3820-7.
9. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007;66:803-6.
10. Martinez A, Mas A, de Las Heras V, Bartolome M, Arroyo R, Fernandez-Arquero M, et al. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity? J Neuroimmunol 2007;189:132-6.
11. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. Analysis of the Fc-receptor like-3 (Fcrl3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007;92:1106-11.
12. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 2005;91:1056-61.
13. Martínez A, Sanchez E, Valdivia A, Orozco G, Lopez-Nevot MA, Pascual-Salcedo D, et al. Epistatic interaction between FCRL3 and NFKB1 genes in Spanish rheumatoid arthritis patients. Ann Rheum Dis 2006;65:1188-91.
14. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, et al. The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 2006;54:1022-5.
15. Eyre S, Bowes J, Potter C, Worthington J, Barton A. Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? Arthritis Res Ther 2006;8:R117.
16. Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum 2006;54:3838-41.
17. Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramon E, et al. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 2006;45:1044-6.
18. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, et al. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet 2006;7:20.
19. Turunen JA, Wessman M, Kilpikari R, Parkkonen M, Forsblom C, Groop PH. The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to type 1 diabetes. Diabet Med 2006;23:925-7.
20. Martínez A, Núñez C, Martín MC, Mendoza JL, Taxonera C, Díaz-Rubio M, et al. Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD. Tissue Antigens 2007;69:313-7.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Lie BA, Viken MK, Odegard S, van der Heijde D, Landewe R, Uhlig T, et al. Associations between the PTPN22 1858C>T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2007;66:1604-9.
24. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
25. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel SouthEastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31:362-6.
26. Mourn B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31:355-61.
27. Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31-9.
28. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
29. Undlien DE, Akselsen HE, Joner G, Dahl-Jorgensen K, Aagenaes O, Sovik O, et al. No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet 1995;57:1511-4.
30. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873-6.
31. Pureed S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50.
32. Barker DL, Hansen MS, Farugi AF, Giannola D, Irsula OR, Lasken RS, et al. Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res 2004;14:901-7.
33. Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005;6:271-3.
34. Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 2002;111:573-4.
35. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-66.
36. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-93.
37. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-21.
38. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
40. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
41. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
42. Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 2007;56:3168-71.
43. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-37.
44. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006;18:214-23.